To evaluate the anti-tumor activity of ACOD1-/- MSLN-CAR-iMACs in vivo, we used two different xenograft solid tumor models with the NOD/SCID/IL2rγnull (NSG) mice. The gene discussed is ACOD1; the disease is neoplasm.